Observation on curative effect of Paecilomyces Hepiall Chen on polycystic ovarian syndrome

LIU Yulan,RUAN Xiangyan,ZHANG Junli

2013-01-01

Abstract:Objective To explore the therapeutic effect of Paecilomyces Hepiall Chen to the patients of polycystic ovarian syndrome(PCOS) with hyperandrogenism; and to provide a theoretical basis and method of choice for reasonable individualized clinical treatment. Methods 30 patients diagnosed as PCOS and hyperandrogenism in Beijing Obstetrics and Gynecology Hospital were chosen and given Paecilomyces Hepiall Chen, three times a day, every time three granules(0.33 g/tablet),continued three months. Monitoring indicators: body mass index(BMI), waist-hip ratio(WHR), body fat(BF%); blood routine(WBC, RBC, HGB, PLT); C-reactive protein(CRP), liver and kidney function tests(ALT, AST, BUN, Cr); lipids(TC, TG,LDL-C, HDL-C); glucose(GLU), insulin(INS), insulin sensitivity index(ISI); endocrine hormones: taken fasting venous blood in the menstrual cycle 2-5 days or no dominant follicle in B-test, and to detect the serum prolactin(PRL), follicle stimulating hormone(FSH), luteinizing hormone(LH), estradiol(E2) and testosterone(T). Results After 3 months' treatment, the measurements of BMI, WHR, BF% had no significant difference, blood lipid: LDL-C was(2.43 ±0.74) mmol/L before treatment, and was(2.14 ±0.53) mmol/L after treatment, the difference was significant(P < 0.05); renal function: Cr was(48.20±17.60) mmol/L before treatment, and increased to(55.80±10.11) mmol/L after treatment, the differences was significant(P < 0.05), BUN, complete blood count, CRP and liver function, the changes of these index had no significant differences, ISI was on the rise. The measurement of androgen was(80.20±32.51) ng/dL before treatment, and reduced to(64.50±24.90) ng/dL after treatment, the change had significant difference(P < 0.05). Conclusion Paecilomyces Hepiall Chen can be used as an option to cut down testosterone in PCOS patients with hyperandrogenism.